Danone : Investors could aim for a turn-around of the trend
BUY
Conditionne
Target price hit
Entry price | Target | Stop-loss | Potential |
---|
€56.7 |
€61.7 |
€54.3 |
+8.82% |
---|
Shares in Danone S.A reflect an interesting technical chart pattern allowing for a bet on a reversal of the medium term trend.
Strengths● This company will be of major interest to investors in search of a high dividend stock.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 55.54.
● Technically, the stock approaches a strong medium-term resistance at EUR 58.1.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company is in debt and has limited leeway for investment
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● Analysts covering the stock have recently lowered their earnings forecast.
● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
● For the past year, analysts have significantly revised downwards their profit estimates.
● Below the resistance at 55.54 EUR, the stock shows a negative configuration when looking looking at the weekly chart.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.